Antibe Therapeutics Inc(Pre-Merger) ATBPF

Hypothetical scenario

[themagicbox]

Lets say Otena is done with our current indication, which I dont believe is the case at all. But as a hypothetical, given how powerful Otena is, I bet that if chronic OA doesn't work at 75mg dose, then we just re-purpose for acute pain instead of 352 to keep company alive.  I see that the focus should be on 346 since its the fatherest along in the trial stages. Everything else starts at square one unfortunately.

Its a larger market and already have Phase 2B proof of concept (with that 2-week acute time horizon) that should be easily repeatable for an acute time frame. Burn rate is still under control and we have the runway to get there. It should proceed more quickly than chronic indication as well, as the chronic is a much longer time horizon. 

All IMO. Food for thought.

[MrMugsy]

---------------------- ahhhhhhh ... not square 1 my friend ... there is real value in what you are saying. October first - then we get updated - we see what's available to us - negotiations out of pause ... that's what matters now. Magic ... Supporting info/documentation re. last conversation ... on its way to you!

[themagicbox]

Much appreciated. thanks MUGs.

[StockingUp21]

Muggy is the fortune teller that tells how to lose your fortune.

[themagicbox]

Useless contribution as always mr. lingerie. Off you go to the dust bin of ignored FUD faries. Say hi to dusty, yukonjizz for brains, and 123 for me. 

[themagicbox]

Looks like my hypothetical scenario turned out to be true ;)  https://www.businesswire.com/news/home/20211014005408/en/Antibe-Therapeutics-Provides-Update-on-Otenaproxesul-and-Expanded-Drug-Pipeline

[muto412]

I think it's nice to have an understanding of where the company is headed. I can't help but be frustrated once again by the vaugeness of their news releases. This quote has me particularly annoyed:  "Importantly, given the relatively short trials required, we feoresee a faster path to market than originally envisaged with our chronic pain program."  "relatively

[Inthepez]

You called right. I’m impressed